Cargando…

Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease

BACKGROUND: Lower leg ischemia, myopathy, and limb dysfunction are distinguishing features of peripheral artery disease (PAD). The myopathy of PAD is characterized by myofiber degeneration in association with extracellular matrix expansion, and increased expression of transforming growth factor-beta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Duy M., Carpenter, Lauren C., Koutakis, Panagiotis, Swanson, Stanley A., Zhu, Zhen, Hanna, Mina, DeSpiegelaere, Holly K., Pipinos, Iraklis I., Casale, George P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743093/
https://www.ncbi.nlm.nih.gov/pubmed/26847457
http://dx.doi.org/10.1186/s12967-016-0790-3
_version_ 1782414295362961408
author Ha, Duy M.
Carpenter, Lauren C.
Koutakis, Panagiotis
Swanson, Stanley A.
Zhu, Zhen
Hanna, Mina
DeSpiegelaere, Holly K.
Pipinos, Iraklis I.
Casale, George P.
author_facet Ha, Duy M.
Carpenter, Lauren C.
Koutakis, Panagiotis
Swanson, Stanley A.
Zhu, Zhen
Hanna, Mina
DeSpiegelaere, Holly K.
Pipinos, Iraklis I.
Casale, George P.
author_sort Ha, Duy M.
collection PubMed
description BACKGROUND: Lower leg ischemia, myopathy, and limb dysfunction are distinguishing features of peripheral artery disease (PAD). The myopathy of PAD is characterized by myofiber degeneration in association with extracellular matrix expansion, and increased expression of transforming growth factor-beta 1 (TGF-β1; a pro-fibrotic cytokine). In this study, we evaluated cellular expression of TGF-β1 in gastrocnemius of control (CTRL) and PAD patients and its relationship to deposited collagen, fibroblast accumulation and limb hemodynamics. METHODS: Gastrocnemius biopsies were collected from PAD patients with claudication (PAD-II; N = 25) and tissue loss (PAD-IV; N = 20) and from CTRL patients (N = 20). TGF-β1 in slide-mounted specimens was labeled with fluorescent antibodies and analyzed by quantitative wide-field, fluorescence microscopy. We evaluated co-localization of TGF-β1 with vascular smooth muscle cells (SMC) (high molecular weight caldesmon), fibroblasts (TE-7 antigen), macrophages (CD163), T cells (CD3) and endothelial cells (CD31). Collagen was stained with Masson Trichrome and collagen density was determined by quantitative bright-field microscopy with multi-spectral imaging. RESULTS: Collagen density increased from CTRL to PAD-II to PAD-IV specimens (all differences p < 0.05) and was prominent around microvessels. TGF-β1 expression increased with advancing disease (all differences p < 0.05), correlated with collagen density across all specimens (r = 0.864; p < 0.001), associated with fibroblast accumulation, and was observed exclusively in SMC. TGF-β1 expression inversely correlated with ankle-brachial index across PAD patients (r = −0.698; p < 0.001). CONCLUSIONS: Our findings support a progressive fibrosis in the gastrocnemius of PAD patients that is caused by elevated TGF-β1 production in the SMC of microvessels in response to tissue hypoxia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0790-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4743093
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47430932016-02-06 Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease Ha, Duy M. Carpenter, Lauren C. Koutakis, Panagiotis Swanson, Stanley A. Zhu, Zhen Hanna, Mina DeSpiegelaere, Holly K. Pipinos, Iraklis I. Casale, George P. J Transl Med Research BACKGROUND: Lower leg ischemia, myopathy, and limb dysfunction are distinguishing features of peripheral artery disease (PAD). The myopathy of PAD is characterized by myofiber degeneration in association with extracellular matrix expansion, and increased expression of transforming growth factor-beta 1 (TGF-β1; a pro-fibrotic cytokine). In this study, we evaluated cellular expression of TGF-β1 in gastrocnemius of control (CTRL) and PAD patients and its relationship to deposited collagen, fibroblast accumulation and limb hemodynamics. METHODS: Gastrocnemius biopsies were collected from PAD patients with claudication (PAD-II; N = 25) and tissue loss (PAD-IV; N = 20) and from CTRL patients (N = 20). TGF-β1 in slide-mounted specimens was labeled with fluorescent antibodies and analyzed by quantitative wide-field, fluorescence microscopy. We evaluated co-localization of TGF-β1 with vascular smooth muscle cells (SMC) (high molecular weight caldesmon), fibroblasts (TE-7 antigen), macrophages (CD163), T cells (CD3) and endothelial cells (CD31). Collagen was stained with Masson Trichrome and collagen density was determined by quantitative bright-field microscopy with multi-spectral imaging. RESULTS: Collagen density increased from CTRL to PAD-II to PAD-IV specimens (all differences p < 0.05) and was prominent around microvessels. TGF-β1 expression increased with advancing disease (all differences p < 0.05), correlated with collagen density across all specimens (r = 0.864; p < 0.001), associated with fibroblast accumulation, and was observed exclusively in SMC. TGF-β1 expression inversely correlated with ankle-brachial index across PAD patients (r = −0.698; p < 0.001). CONCLUSIONS: Our findings support a progressive fibrosis in the gastrocnemius of PAD patients that is caused by elevated TGF-β1 production in the SMC of microvessels in response to tissue hypoxia. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0790-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-04 /pmc/articles/PMC4743093/ /pubmed/26847457 http://dx.doi.org/10.1186/s12967-016-0790-3 Text en © Ha et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ha, Duy M.
Carpenter, Lauren C.
Koutakis, Panagiotis
Swanson, Stanley A.
Zhu, Zhen
Hanna, Mina
DeSpiegelaere, Holly K.
Pipinos, Iraklis I.
Casale, George P.
Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease
title Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease
title_full Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease
title_fullStr Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease
title_full_unstemmed Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease
title_short Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease
title_sort transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743093/
https://www.ncbi.nlm.nih.gov/pubmed/26847457
http://dx.doi.org/10.1186/s12967-016-0790-3
work_keys_str_mv AT haduym transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease
AT carpenterlaurenc transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease
AT koutakispanagiotis transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease
AT swansonstanleya transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease
AT zhuzhen transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease
AT hannamina transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease
AT despiegelaerehollyk transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease
AT pipinosiraklisi transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease
AT casalegeorgep transforminggrowthfactorbeta1producedbyvascularsmoothmusclecellspredictsfibrosisinthegastrocnemiusofpatientswithperipheralarterydisease